Your browser doesn't support javascript.
loading
Does an Alternative Sunitinib Dosing Schedule Really Improve Survival Outcomes over a Conventional Dosing Schedule in Patients with Metastatic Renal Cell Carcinoma? An Updated Systematic Review and Meta-Analysis.
Chung, Doo Yong; Kang, Dong Hyuk; Kim, Jong Won; Kim, Do Kyung; Lee, Joo Yong; Hong, Chang Hee; Cho, Kang Su.
Afiliación
  • Chung DY; Department of Urology, Inha University School of Medicine, Incheon 22212, Korea.
  • Kang DH; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul 06273, Korea.
  • Kim JW; Department of Urology, Inha University School of Medicine, Incheon 22212, Korea.
  • Kim DK; Department of Urology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Korea.
  • Lee JY; Department of Urology, Soonchunhyang University Seoul Hospital, Soonchunhyang University Medical College, Seoul 06273, Korea.
  • Hong CH; Department of Urology, Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Korea.
  • Cho KS; Department of Urology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Korea.
Cancers (Basel) ; 11(12)2019 Nov 21.
Article en En | MEDLINE | ID: mdl-31766332
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Systematic_reviews Idioma: En Revista: Cancers (Basel) Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Systematic_reviews Idioma: En Revista: Cancers (Basel) Año: 2019 Tipo del documento: Article